ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L04AA10 | B | Sirolimus - 1mg | 9983 | 20119/1 | RAPAMUNE | 1mg | 100 | Tablet | Oral | Food & Drug Corporation FDC | Pfizer Ireland Pharmaceuticals | Ireland | 613,810 L.L | 10.71 | E1 | Pfizer Inc | USA | 12/5/202 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L04AA10 | G | Sirolimus - 1mg | 7348 | 167540/10 | SIROMUNE | 1mg | 100 | Tablet, film coated | Oral | Benta Trading Co s.a.l. | Benta SAL | Lebanon | 12,107,459 L.L | 19.35 | D | 12/5/202 | raw material 45% | ||
L04AA10 | B | Sirolimus - 1mg | 9983/945 | 20119/1 | RAPAMUNE | 1mg | 100 | Tablet | Oral | Food & Drug Corporation FDC | Pfizer Ireland Pharmaceuticals | Ireland | 37,630,936 L.L | 10.71 | E1 | Pfizer Inc | USA | 12/5/202 | 0 |